Solène Bardin1,2, Michele Lecis1,3, Davide Boido1,2, Fawzi Boumezbeur1,2, and Luisa Ciobanu1,2
1NeuroSpin, CEA, Gif-sur-Yvette, France, 2Paris-Saclay University, Saclay, France, 3Technical University of Munich, Munich, Germany
Synopsis
Accelerated
CEST acquisitions using a linescan sequence coupled with an ultra-high magnetic
field allows, for the first time, the detection of carnosine in vivo.
Introduction
Chemical
Exchange Saturation Transfer (CEST) has demonstrated enhanced in vivo detection sensitivity for
numerous metabolites including glutamate [1], glucose [2] and creatine [3]. In
this study, we reveal, for the first time, the in vivo detection of carnosine using CEST-linescan MRI in the rat lower-leg muscle. Material and Methods
All measurements were performed on a 17.2T preclinical
scanner (Bruker Biospin, Germany). The CEST acquisitions were performed using in-house
developed pulse sequences. Specifically,
we used either a zPREST [4] sequence or a CEST-linescan sequence. The CEST-linescan,
developed according to [5], uses magnetic field gradients for spatial encoding
during the saturation pulse and allows a dramatic reduction of the acquisition time
needed for a complete Z-spectrum (16s vs 13min28s for zPREST). Direct detection
and quantification of carnosine was performed using a LASER sequence [6].
In vitro A 15mL Falcon tube was filled with 20mM solution of
carnosine diluted in
0.01M PBS and adjusted to pH 7.0. The sample was maintained at (37 ± 1) °C during scanning.
In vivo Four male Dark Agouti rats (250-300g) were scanned under isoflurane anaesthesia and
controlled physiological conditions using a pair of surface/volume coils (Rapid
Biomedical, Germany). Anatomical images of the lower-leg
muscle were acquired using a RARE sequence (TE/TR=8/2000ms, in plane resolution=
140x140 µm2, slice thickness=1 mm).
CEST-linescan
acquisitions were subsequently performed along a line parallel to the bone (Fig. 3A) with the following acquisition parameters: TE/TR=3/8000ms, slice/line thickness=3/1.8mm, resolution along the
line=70 µm; CEST saturation
module: 10 square pulses of 400ms and B1=1µT, 64 saturation offsets
from -5 to 5ppm or from 0.8 to 4.3 ppm. 80 repetitions (pairs of lines with and
without the saturation) were acquired to increase the SNR for a total
acquisition time of 21m20s.
Data analysis
To obtain the Z-spectra, CEST data were processed as follows:
-zPREST: For each saturation offset, the data was
Fourier transformed, the integral of the water peak was computed and normalized
by a reference signal at ẟ=10ppm.
-CEST-linescan: The ratio between the Fourier transforms of the signal
acquired with and without saturation was plotted against the saturation
offsets.
The peaks in any given Z-spectrum were automatically detected and the
statistical significance calculated using an in-house built, Python based, algorithm
whose principles are illustrated in Fig. 1. This algorithm also computes the carnosine
peak amplitude with respect to the corresponding baseline (in %).Results
In vitro
Figure 2
shows three different acquisitions performed on a 20 mM carnosine solution. Localized
1H NMR spectroscopy provides the signature of carnosine (Fig. 2A). The CEST acquisitions, zPREST (Fig. 2B) and CEST-linescan (Fig. 2C), show a small decrease in the water signal at approximately (3.30
± 0.5) ppm (this is somewhat shifted from 3.1 ppm
reported in [7], most likely due to the difference in pH). The CEST acquisitions were performed using a
saturation power B1=1µT,
which was experimentally found as being the optimal value for carnosine
detection.
When
comparing the SNR of the two CEST acquisitions we found similar values, 20.4 for
CEST-linescan vs 22.6 for zPREST, both obtained for an acquisition time of
13min28s, which is the minimum necessary for a single average zPREST acquisition.
However, given the much shorter time required for the acquisition of one single
CEST linescan Z-spectrum, this sequence
offers increased signal stability especially for in vivo acquisitions as a larger variability over time is expected (due
to frequency drifts and other physiological noises).
In vivo
Figure 3 presents
the in vivo rat leg muscle results obtained
with the CEST-linescan approach (position depicted by the orange rectangle in
Fig. 3A). On the full Z-spectrum (Fig. 3C), we recognize the peaks corresponding
to NOE on the right, and creatine (Cr) and phosphocreatine (PCr) on the left [8].
By increasing the strength of the CEST saturation gradient, we obtain a higher
resolution Z-spectrum (Fig. 3D) spanning a smaller frequency range. Here the Cr and
PCr peaks are better defined and we detect two additional peaks corresponding
to APT at (3.45 ± 0.05) ppm and carnosine (Car) at (3.30
± 0.05) ppm (see also the zoom in Fig. 3E, the
empty circles correspond to data from an additional animal). Similar results
were obtained on all four animals with an average carnosine peak amplitude of
(0.14 ± 0.06) %. 1H-MRS confirmed the presence of carnosine for
all animals. Figure 3B shows the 1H spectrum obtained for rat 1 and acquired
in the green voxel (Fig. 3A). From the decomposition of the 1H-MRS
spectra using LCModel [9], we estimate an average (N=4 animals) Car concentration
of (10 ± 2) mM considering a Cr+PCr concentration of 38 mM.Discussion and Conclusion
Accelerated CEST acquisitions using a linescan
sequence coupled with an ultra-high magnetic field allowed, for the first time,
the detection of carnosine in vivo. While we present acquisition performed on a
leg muscle, such studies can also be extended to the brain especially in areas
with high carnosine concentration (e.g. the olfactory bulb). Indeed, carnosine
is a molecule of interest since it is involved in antioxidant activities and
has neuroprotective properties [10].Acknowledgements
This research was supported by a public grant
overseen by the ANR and DFG under the project name BAMBOO. The authors thank Dr. C.I. Ciobanu for his help with data
analysis and E. Selingue for managing the animal preparation and welfare. References
[1] K. Cai,
M. Harris, A. Singh et al. Magnetic
resonance imaging of glutamate, Nature Med, 18, 302-306, 2012.
[2] K. Chan, M. McMahon, Y.
Kato et al. Natural D-glucose as a biodegradable MRI contrast
agent for detecting cancer, Magn Reson Med, 68(6):1764-73, 2012.
[3] M.Harris, R. Nanga,
A.Singh et al. Exchange rates of creatine
kinase metabolites: feasibility of imaging creatine by chemical exchange
saturation transfer MRI, NMR Biomed, 25(11):1305-9, 2012.
[4] T. Roussel, P. Svehla, D.
Le Bihan et al. The origins of CEST contrast in ischemic tissue: effects of
hypotonic stress on the nervous system of Aplysia californica, ISMRM, 2017.
[5] X. Xu, J-S. Lee and A. Jerschow. Ultrafast Scanning of Exchangeable
Sites by NMR Spectroscopy Xiang, Angewandte Chemie, 125(32):8439-8442, 2013.
[6] M. Garwood, L.
DelaBarre The return of the frequency sweep: designing adiabatic pulses for
contemporary NMR. J Mag Reson, 153:155-177, 2001.
[7] O. Bodet, S. Goerke, N.Behl et al. Amide proton transfer of carnosine in aqueous
solution studied in vitro by WEX and CEST experiments, NMR in Biomed,
28(9):1097-1103, 2015.
[8] K. Pavuluri, J. Rosenberg, S. Helsper et al. Amplified detection of phosphocreatine
and creatine after supplementation using CEST MRI at high and ultrahigh fields,
J Mag Reson, 313, 2020.
[9] S.W. Provencher.
Estimation of metabolite concentrations from localized in vivo proton NMR
spectra. Magn Reson Med, 30(6):672-9, 1993.
[10] S.
Jain, E-S. Kim, D. Kim et al. Comparative Cerebroprotective Potential of D- and
L-Carnosine Following Ischemic Stroke in Mice, Int J Mol Sci, 21(9):3053, 2020.